구글 검색

검색어: fucosyllactose (프랑스어 - 영어)

인적 기여

전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.

번역 추가

프랑스어

영어

정보

프랑스어

synthèse de 2'- o-fucosyllactose

영어

synthesis of 2'- o-fucosyllactose

마지막 업데이트: 2011-07-27
사용 빈도: 1
품질:

프랑스어

SYNTHÈSE DE 2'-O-FUCOSYLLACTOSE

영어

SYNTHESIS OF 2'-O-FUCOSYLLACTOSE

마지막 업데이트: 2011-07-27
사용 빈도: 1
품질:

프랑스어

Utilisation selon la revendication 2, dans laquelle ledit oligosaccharide est le lacto-N-fucopentose ou le 3-fucosyllactose.

영어

Use as claimed in claim 2 wherein said oligosaccharide is lacto-N-fucopentaose or 3-fucosyllactose.

마지막 업데이트: 2014-12-04
사용 빈도: 2
품질:

프랑스어

Procédé selon l'une quelconque des revendications 1 à 20 pour la production de 3'fucosyllactose β-D-Gal-[1→4]-(α-L-Fuc-(1→3])-D-Glc ou de 2'fucosyllactose α-L-Fuc-[1→2]-β-D-Gal-[1→4]-D-Glc caractérisé en ce qu' il comprend un dit enzyme choisit parmi l'α-1,3 fucosyltransférase ou l'α-1,2 fucosyltransférase, et que la cellule a un génotype wcaj - lacZ- et surexprime le gène rcsA et que ledit précurseur est le lactose.

영어

Method according to any one of Claims 1 to 20, for the production of 3'-fucosyllactose (β-D-Gal-[1→4]-(α-L-Fuc-[1→3]-D-Glc) or 2' -fucosyllactose, α-L-Fuc-[1→2]-β-D-Gal-[1→4]-D-Glc characterized in that it comprises a said enzyme chosen from α-1,3-fucosyl-transferase or α-1,2-fucosyl-transferase, and in that the cell has a wcaj - lacZ - genotype and overexpresses the rcsA gene and in that said precursor is lactose.

마지막 업데이트: 2014-12-04
사용 빈도: 2
품질:

프랑스어

N-acryloylglycosylamine ou N-méthacryloylglycosylamine selon la revendication 10, dans lesquelles R 2 représente le résidu d'un saccharide choisi parmi le lactose, le lacto-N-tétrose, le facto-N-fucopentose I, le lacto-N-fucopentose II, le lacto-N-difucohexose I, le 2'-fucosyllactose, le 3'-siallyllactose, le A-tétrasaccharide, le cellobiose.

영어

An N-acryloyl- or methacryloyl-glycosylamine according to claim 10, wherein R 2 is the residue of a saccharide selected from: lactose, lacto-N-tetraose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-difucohexaose I, 2'-fucosyllactose, 3'-siallyllactose, A-tetrasaccharides, cellobiose.

마지막 업데이트: 2014-12-04
사용 빈도: 2
품질:

프랑스어

Copolymère selon la revendication 3, dans lequel R 2 représente le résidu d'un saccharide choisi parmi le lactose, le lacto-N-tétrose, le lacto-N-fucopentose I, le lacto-N-fucopentose II, le lacto-N-difucohexose I, le 2'-fucosyllactose, le 3'-siallyllactose, le A-tétrasaccharide, le cellobiose.

영어

A copolymer according to claim 3, wherein R 2 is the residue of a saccharide selected from: lactose, lacto-N-tetraose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-difucohexaose I, 2'-fucosyllactose, 3'-siallyllactose, A-tetrasaccharide, cellobiose.

마지막 업데이트: 2014-12-04
사용 빈도: 2
품질:

프랑스어

L'invention a trait à une formulation nutritionnelle contenant au moins l'un des oligosaccharides suivants: de 400 environ à 3500 mg/l environ de 3-fucosyllactose, de 200 environ à 2200 mg/l environ de lacto-N-fucopentaose III, de 100 environ à 1500 mg/l environ de lacto-N-fucopentaose II, de 100 environ à 2500 mg/l environ de difucosyllactose, de 500 environ à 4500 mg/l environ de 2' fucosyllactose, de 250 environ à 3300 mg/l environ de lacto-N-fucopentaose I, de 100 environ à 900 mg/l environ de Lacto-N-néoTétraose, de 50 environ à 2300 mg/l environ de lacto-N-fucopentaose V ou bien de 300 environ à 2800 mg/l environ de lacto-N-tétraose.

영어

A nutritional formulation containing at least one of the following oligosaccharides: from about 400 to about 3500 mg/L of 3-fucosyllactose; from about 200 to about 2200 mg/L of lacto-N-fucopentaose III; from about 100 to about 1500 mg/L of lacto-N-fucopentaose II; from about 100 to about 2500 mg/L of difucosyllactose; from about 500 to about 4500 mg/L of 2'fucosyllactose; from about 250 to about 3500 mg/L of lacto-N-fucopentaose I; from about 100 to about 900 mg/L of Lacto-N-neoTetraose; from about 50 to about 2300 mg/L of lacto-N-fucopentaose V; or from about 300 to about 2800 mg/L of lacto-N-tetraose.

마지막 업데이트: 2014-12-03
사용 빈도: 1
품질:

프랑스어

L'invention concerne une composition destinée à la prévention d'infections opportunistes chez des individus immunodéprimés, laquelle composition comprend un probiotique Bifidobacterium lactis, Bifidobacterium infantis, Bifidobacterium breve ou Bifidobacterium longum et un oligosaccharide fucosylé choisi dans le groupe comprenant le 2'-fucosyllactose, le 3 'fucosyllactose, le difucosyllactose, le lacto-N-fucopentaose, le lacto-N-fucohexaose, le fucosyllacto-N-hexaose et le fucosyllacto-N- néohexaose. L'invention se rapporte en outre à l'utilisation de ladite composition dans la prévention d'infections opportunistes chez des individus immunodéprimés.

영어

This invention relates to a composition suitable for use in the prevention of opportunistic infections in immune-compromised individuals comprising a probiotic Bifidobacterium lactis, Bifidobacterium infantis, Bifidobacterium breve or Bifidobacterium longum and a fucosylated oligosaccharide selected from the group comprising 2'-fucosyllactose, 3 'fucosyllactose, difucosyllactose, lacto-N- fucopentaose, lacto-N-fucohexaose, fucosyllacto-N-hexaose and fucosyllacto-N- neohexaose. The invention further extends to the use of such a composition in the prevention of opportunistic infections in immune-compromised individuals.

마지막 업데이트: 2011-07-27
사용 빈도: 1
품질:

프랑스어

L'invention a trait à une formulation nutritionnelle contenant au moins l'un des oligosaccharides suivants: de 400 environ à 3500 mg/l environ de 3-fucosyllactose, de 200 environ à 2200 mg/l environ de lacto-N-fucopentaose III, de 100 environ à 1500 mg/l environ de lacto-N-fucopentaose II, de 100 environ à 2500 mg/l environ de difucosyllactose, de 500 environ à 4500 mg/l environ de 2' fucosyllactose, de 250 environ à 3300 mg/l environ de lacto-N-fucopentaose I, de 100 environ à 900 mg/l environ de Lacto-N-néoTétraose, de 50 environ à 2300 mg/l environ de lacto-N-fucopentaose V ou bien de 300 environ à 2800 mg/l environ de lacto-N-tétraose.

영어

A nutritional formulation containing at least one of the following oligosaccharides: from about 400 to about 3500 mg/L of 3-fucosyllactose; from about 200 to about 2200 mg/L of lacto-N-fucopentaose III; from about 100 to about 1500 mg/L of lacto-N-fucopentaose II; from about 100 to about 2500 mg/L of difucosyllactose; from about 500 to about 4500 mg/L of 2'fucosyllactose; from about 250 to about 3500 mg/L of lacto-N-fucopentaose I; from about 100 to about 900 mg/L of Lacto-N-neoTetraose; from about 50 to about 2300 mg/L of lacto-N-fucopentaose V; or from about 300 to about 2800 mg/L of lacto-N-tetraose.

마지막 업데이트: 2011-07-27
사용 빈도: 1
품질:

인적 기여로
4,401,923,520 더 나은 번역을 얻을 수 있습니다

사용자가 도움을 필요로 합니다:



당사는 사용자 경험을 향상시키기 위해 쿠키를 사용합니다. 귀하께서 본 사이트를 계속 방문하시는 것은 당사의 쿠키 사용에 동의하시는 것으로 간주됩니다. 자세히 보기. 확인